BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 2549426)

  • 1. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.
    Landis CA; Masters SB; Spada A; Pace AM; Bourne HR; Vallar L
    Nature; 1989 Aug; 340(6236):692-6. PubMed ID: 2549426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GTPase-inhibiting mutations activate the alpha-chain of Gs in human tumours.
    Vallar L
    Biochem Soc Symp; 1990; 56():165-70. PubMed ID: 2124121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis in Escherichia coli of GTPase-deficient mutants of Gs alpha.
    Graziano MP; Gilman AG
    J Biol Chem; 1989 Sep; 264(26):15475-82. PubMed ID: 2549065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the GTP-binding site of GS alpha alter stimulation of adenylyl cyclase.
    Masters SB; Miller RT; Chi MH; Chang FH; Beiderman B; Lopez NG; Bourne HR
    J Biol Chem; 1989 Sep; 264(26):15467-74. PubMed ID: 2549064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new constitutively activating mutation of the Gs protein alpha subunit-gsp oncogene is found in human pituitary tumours.
    Clementi E; Malgaretti N; Meldolesi J; Taramelli R
    Oncogene; 1990 Jul; 5(7):1059-61. PubMed ID: 2115641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two G protein oncogenes in human endocrine tumors.
    Lyons J; Landis CA; Harsh G; Vallar L; Grünewald K; Feichtinger H; Duh QY; Clark OH; Kawasaki E; Bourne HR
    Science; 1990 Aug; 249(4969):655-9. PubMed ID: 2116665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GTPase-inhibiting mutations in the alpha subunit of Gs.
    Masters SB; Landis CA; Bourne HR
    Adv Second Messenger Phosphoprotein Res; 1990; 24():70-5. PubMed ID: 2119660
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydrolysis of GTP by the alpha-chain of Gs and other GTP binding proteins.
    Bourne HR; Landis CA; Masters SB
    Proteins; 1989; 6(3):222-30. PubMed ID: 2516316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G protein amino-terminal alpha i2/alpha s chimeras reveal amino acids important in regulating alpha s activity.
    Russell M; Johnson GL
    Mol Pharmacol; 1993 Aug; 44(2):255-63. PubMed ID: 8394989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-protein oncogenes in acromegaly.
    Spada A; Vallar L
    Horm Res; 1992; 38(1-2):90-3. PubMed ID: 1306524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors.
    Adams EF; Brockmeier S; Friedmann E; Roth M; Buchfelder M; Fahlbusch R
    Neurosurgery; 1993 Aug; 33(2):198-203; discussion 203. PubMed ID: 8396223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant alpha subunits of Gi2 inhibit cyclic AMP accumulation.
    Wong YH; Federman A; Pace AM; Zachary I; Evans T; Pouysségur J; Bourne HR
    Nature; 1991 May; 351(6321):63-5. PubMed ID: 1851251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome.
    Schwindinger WF; Francomano CA; Levine MA
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):5152-6. PubMed ID: 1594625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating mutations of the Gs alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors.
    Ballaré E; Mantovani S; Lania A; Di Blasio AM; Vallar L; Spada A
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4386-90. PubMed ID: 9851782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors.
    Tordjman K; Stern N; Ouaknine G; Yossiphov Y; Razon N; Nordenskjöld M; Friedman E
    J Clin Endocrinol Metab; 1993 Sep; 77(3):765-9. PubMed ID: 8396579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase.
    Spada A; Arosio M; Bochicchio D; Bazzoni N; Vallar L; Bassetti M; Faglia G
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1421-6. PubMed ID: 1977758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenomas: screening for G alpha q mutations.
    Oyesiku NM; Evans CO; Brown MR; Blevins LS; Tindall GT; Parks JS
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4184-8. PubMed ID: 9398737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of G protein alpha subunit mutations in human growth hormone (GH)- and GH/prolactin-secreting pituitary tumors by single-strand conformation polymorphism (SSCP) analysis.
    Drews RT; Gravel RA; Collu R
    Mol Cell Endocrinol; 1992 Sep; 87(1-3):125-9. PubMed ID: 1446784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the alpha subunit of the stimulatory regulatory protein of adenylyl cyclase (Gs) in human GH-secreting pituitary adenomas. Biochemical, clinical, and morphological aspects.
    Spada A; Arosio M; Bassetti M; Vallar L; Clementi E; Bazzoni N
    Pathol Res Pract; 1991 Jun; 187(5):567-70. PubMed ID: 1923949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human-Xenopus chimeras of Gs alpha reveal a new region important for its activation of adenylyl cyclase.
    Antonelli M; Birnbaumer L; Allende JE; Olate J
    FEBS Lett; 1994 Mar; 340(3):249-54. PubMed ID: 8131853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.